Ara mostrant els elements 41-50 de 57
Guerrero Hernández, Martina (Data de defensa: 2019-02-19)
The tumor microenvironment (TME) is gaining momentum due to its contribution to cancer progression and therapy resistance. This TME has a direct crosstalk with tumor cells that involves the activation ...
García de Albéniz, Xabier (Data de defensa: 2015-04-15)
We studied the mechanisms driving the metastatic spread in colorectal cancer (CRC), focusing in the MAPK pathway. We developed in vivo a highly metastatic cell line using a KRAS-mutated cell line (SW620) ...
Morcelle Magaña, Carmen (Data de defensa: 2017-09-19)
In most human cancers, the c-Myc transcription factor is deregulated and/or its levels are elevated, particularly in colorectal cancer (CRC). Earlier studies suggested a direct relationship between ...
Farrera Sal, Martí (Data de defensa: 2020-10-30)
The oncolytic viruses (OVs) preferentially infect tumor and selectively replicate in cancer cells without harming normal tissues. OVs have been tested in clinical trials as monotherapy or combined with ...
Duch Gili, Paula (Data de defensa: 2022-03-14)
Increased expression of TIMP-1 is associated with poor prognosis in virtually all cancer types, including lung cancer. However, how TIMP-1 is regulated in lung cancer and how it drives tumor progression ...
Coll Iglesias, Laura (Data de defensa: 2022-11-23)
[eng] Endometrial cancer represents the most common cancer arising from the uterine cavity and there is little hope for patients with recurrent or metastatic disease. Prior studies of our group reported ...
Fernández Martínez, Aranzazu (Data de defensa: 2021-07-16)
[eng] HR-positive/HER2-negative (HR+/HER2-) is the most common breast cancer type, and it is a molecular heterogenic disease. This heterogeneity has direct prognostic and predictive implications in both ...
Montironi, Carla (Data de defensa: 2022-06-20)
[eng] INTRODUCTION: Liver cancer is a devastating disease and represents the seventh most common cancer worldwide and the third leading cause of cancer-related death globally. Hepatocellular carcinoma ...
Bergamino Sirvén, Milana Arantza (Data de defensa: 2022-11-29)
[eng] 80% of breast cancer (BC) express positive estrogen receptors (ER+) and up to 15% of them also overexpress or amplify the human epidermal growth factor receptor 2 (HER2), which confers a molecular ...
Garcia Mulero, Sandra (Data de defensa: 2022-12-16)
[eng] Cancer is a heterogeneous disease, in which many cell types interact with cancer cells, forming a complex network. The crosstalk between the cancer cells and the immune microenvironment is determinant ...